All news from Transfusion Medicine

Transfusion Medicine

Ultrasound For Thrombosis Prevention

A new approach for the prevention of thrombosis was proposed by researchers from the Moscow Institute of Physics and Technology (MIPT) and the Russian National Research Center for Hematology (NRCH). In modern clinical practice, thrombolytic is perform when thrombi form in blood vessels pose a threat to a patient’s life. Thrombolytic procedures themselves are associate…

Transfusion medicine

Treosulfan Better Than Busulfan In Prep For HSCT

Using a treosulfan-based myeloablative regimen in place of one based on busulfan may improve survival in vulnerable patients with acute myeloid leukemia and myelodysplastic syndrome about to undergo allogeneic hematopoietic cell transplantation (HSCT), say German researchers reporting results from a phase 3 study. Effect of treosulfan The researchers compared the effect of treosulfan/fludarabine regimens with those containing busulfan/fludarabine…

Transfusion medicine

Increase In Adverse Outcomes For People Taking Aspirin And Warfarin

A daily aspirin is a commonly use, generally safe therapy for people who need help preventing heart attacks or stroke. But new Michigan Medicine research finds more reason to reconsider aspirin use when a patient is also taking an anticoagulant. The study, just published in JAMA Internal Medicine, reveals a significant increase in adverse outcomes for…

transfusion medicine

Anti platelet Therapy Considerations In Women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women’s Cardiovascular Health, Volume 3, Number 4, 2019; Guest Editor Gladys P. Velarde) Khadeeja Esmail and Dominick J. Angiolillo from the University of Florida Medical School, Gainesville, FL, USA review anti platelet therapy considerations in women. Important implications The authors provide a detailed review of…

Transfusion Medicine

Young Blood' Clinics Shut Down After FDA Action

Ambrosia Health has shut down its clinics offering transfusions of young blood plasma after the FDA issued a statement saying the science was unproven. “In compliance with the FDA announcement issued February 19, 2019, we have ceased patient treatments,” says a statement on Ambrosia Health’s website. Medical school Earlier in 2019, entrepreneur and Stanford University…

Transfusion medicine

New Blood Drop Emoji Due To Hit Smartphone Keyboards

Blood donors can soon use their time in the donation chair to let people know they are saving lives using a new blood drop emoji. because The long-awaited red blood drop, which was a successful submission to Unicode from NHS Blood and Transplant along with Plan International UK, is on the list of the new…

Transfusion Mediine

FDA OKs Turoctocog Alfa Pegol For Hemophilia A

The US Food and Drug Administration (FDA) has approved turoctocog alfa pegol  for patients with hemophilia A, a hereditary disorder caused by a lack of the blood clotting factor VIII protein. Because Turoctocog alfa pegol  is an extended half-life glycopegylated factor VIII molecule for adults and children with hemophilia A. It is indicated for control and prevention of…

Transfusion Medicine

Anti platelet Therapy Reduce Risk Of Blood Clots Prevent Cancer Metastasis

A new reversible, drug-free anti platelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine. The therapeutic approach involves modifying human platelets to create “decoys” that are still capable of binding to some cells but will not aggregate or carry out the…

Transfusion Medicine

Blood Cells Could Hold Master Clock Behind Aging

Blood cells could hold the key to aging, according to new research out of Case Western Reserve University School of Medicine. In a study published in Aging Cell, researchers found human blood cells have an intrinsic clock that remains steady even after the transplant. The researchers say the clock could control human aging and may underlie…

Blood transfusion

Retroperitoneal Lymph Node Dissection Demonstrates

Retroperitoneal lymph node dissection conferred favorable survival rates among men with testicular seminoma used as first-line therapy or following chemotherapy, according to study results presented at Genitourinary Cancers Symposium. “Although retroperitoneal lymph node dissection is rarely used as primary therapy in these men; overall survival rates appear to be favorable,” Thomas L. Jang, MD, MPH, FACS, a urologic oncologist…

Transfusion

A Regression Model For Prediction Of Cesarean-Associated Blood Transfusion

Red blood cell transfusion occurs in approximately 3% of all cesarean deliveries1 with massive transfusion, variably defined as red blood cell transfusion of more than 8 or 10 units, complicating 0.23 and 0.06% of deliveries, respectively. In the United States, the rate of severe maternal morbidity; including the rate of red blood cell transfusion during and…